Bruce Jackson
Stock Analyst at Benchmark
(0.87)
# 3,865
Out of 4,964 analysts
122
Total ratings
25.23%
Success rate
-23.77%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CV CapsoVision | Initiates: Speculative Buy | $5 | $3.93 | +27.23% | 1 | Jul 28, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.85 | +222.96% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $1.58 | +786.08% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.52 | +476.70% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $5.41 | +509.98% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $3.53 | +551.56% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $64.75 | +23.55% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $7.21 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $46.95 | +38.45% | 7 | Jan 13, 2025 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.66 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $4.20 | +614.29% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.61 | +105.93% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.21 | +147.93% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.00 | +150.00% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $0.62 | +4,757.51% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $3.86 | +1,454.40% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.46 | +3,593.24% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $1.29 | +1,760.47% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.74 | +575.40% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.04 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $27.40 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.40 | +23,429.41% | 1 | Aug 8, 2022 |
CapsoVision
Jul 28, 2025
Initiates: Speculative Buy
Price Target: $5
Current: $3.93
Upside: +27.23%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.85
Upside: +222.96%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $1.58
Upside: +786.08%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.52
Upside: +476.70%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $5.41
Upside: +509.98%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $3.53
Upside: +551.56%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $64.75
Upside: +23.55%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.21
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $46.95
Upside: +38.45%
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.66
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $4.20
Upside: +614.29%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.61
Upside: +105.93%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.21
Upside: +147.93%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.00
Upside: +150.00%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $0.62
Upside: +4,757.51%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $3.86
Upside: +1,454.40%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.46
Upside: +3,593.24%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $1.29
Upside: +1,760.47%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.74
Upside: +575.40%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.04
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $27.40
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.40
Upside: +23,429.41%